TVRD

Tvardi Therapeutics
TVRD

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$38
913% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Raymond James
Raymond James
Ryan Deschner
0% 1-yr TVRD win rate
14 Oct ‘25 1 month ago
BTIG
BTIG
Julian Harrison
0% 1-yr TVRD win rate
13 Oct ‘25 1 month ago
Barclays
Barclays
Etzer Darout
0% 1-yr TVRD win rate
13 Oct ‘25 1 month ago